Impact of a Raltegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS Patients

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified March 2015 by Fundação Bahiana de Infectologia
Sponsor:
Information provided by (Responsible Party):
Carlos Brites, Fundação Bahiana de Infectologia
ClinicalTrials.gov Identifier:
NCT01837277
First received: April 18, 2013
Last updated: March 5, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)